Literature DB >> 30631567

Examining EML4-ALK variants in the clinical setting: the next frontier?

Malini Patel1, Jyoti Malhotra1, Salma K Jabbour1.   

Abstract

Entities:  

Year:  2018        PMID： 30631567      PMCID： PMC6297451          DOI： 10.21037/jtd.2018.11.07

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  3 in total

1.  Rapid detection and genotyping of ALK fusion variants by adapter multiplex PCR and high-resolution melting analysis.

Authors:  Mei Li; Shen Lu; Xu Sun
Journal:  Lab Invest       Date:  2019-10-22       Impact factor: 5.662

Review 2.  Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer.

Authors:  Savvas Papageorgiou; Sarah L Pashley; Laura O'Regan; Sam Khan; Richard Bayliss; Andrew M Fry
Journal:  Cancers (Basel)       Date:  2022-07-15       Impact factor: 6.575

Review 3.  EML4-ALK fusion gene in non-small cell lung cancer.

Authors:  Yu Lei; Yan Lei; Xiang Shi; Jingjing Wang
Journal:  Oncol Lett       Date:  2022-06-24       Impact factor: 3.111
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.